SCHEMBL4058032

SCHEMBL4058032

Cc1cc(Cc2cc(C)c(C)c(CO)c2O)c(O)c(CO)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.42
HSD17B10 Q99714 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HSPA5 P11021 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
AMY1A P0DUB6 1/20 0.37
HIF1A Q16665 4/20 0.36
CYP2C9 P11712 3/20 0.36
CYP2C19 P33261 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CYP2D6 P10635 1/20 0.36
CYP1A2 P05177 1/20 0.34
ALOX15 P16050 1/20 0.34
CASP7 P55210 1/20 0.34
TRPV4 Q9HBA0 1/20 0.33
DRD4 P21917 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8345472 0.93 SHBG (0.42) SHBGHSD17B10ALDH1A1HSPA5KDM4E
SCHEMBL8351608 0.89 SHBG (0.40) SHBGHSD17B10ALDH1A1HSPA5KDM4E
SCHEMBL2219441 0.89 SHBG (0.48) SHBGHSD17B10ALDH1A1KDM4EHPGD
SCHEMBL12175480 0.85 SHBG (0.48) SHBGHSD17B10ALDH1A1HSPA5KDM4E
SCHEMBL212514 0.83 SHBG (0.47) SHBGHSD17B10ALDH1A1HSPA5KDM4E
SCHEMBL7523362 0.80 SHBG (0.44) SHBGHSD17B10ALDH1A1HSPA5KDM4E
SCHEMBL7529731 0.80 SHBG (0.44) SHBGHSD17B10ALDH1A1HSPA5KDM4E
SCHEMBL7094938 0.80 AMY1A (0.47) SHBGHSD17B10ALDH1A1HSPA5KDM4E
SCHEMBL22271434 0.79 SHBG (0.43) SHBGHSD17B10ALDH1A1HSPA5KDM4E
SCHEMBL22039928 0.78 SHBG (0.40) SHBGHSD17B10ALDH1A1HSPA5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM SHBG 3960/4885HSD17B10 3699/4885ALDH1A1 1552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.